Accueil Healthcare Europe DOA Testing Market Survey and In-depth Analysis on Industry Growth Factors, Trends, and Forecast 2023

Europe DOA Testing Market Survey and In-depth Analysis on Industry Growth Factors, Trends, and Forecast 2023

Europe Drug of Abuse Testing Market

The Europe Drug of Abuse testing market is forecasted to reach $3.0 billion by 2023. Growing alcohol consumption, rising drug trafficking, and increasing government initiatives that aim at increasing interdiction capacities and strengthening law enforcement in the region are some notable factors supporting the demand for DOA testing products and services in the region.

Download free report sample at:

The products category held larger share, of 80.1%, in the European DOA testing market in 2017. This category is predicted to grow at a CAGR of 9.2% during the forecast period, mainly due to the increasing number of drug abuse cases, development of technologically advanced products, and increasing awareness toward DOA testing in the region.

The products in the DOA testing market in Europe are further sub-categorized into consumables and equipment. The consumables used for DOA testing are rapid test kits, assay kits and reagents, and others. Of these, rapid test kits held the largest share in the European DOA testing consumables market, and generated more than $400.0 million revenue in 2017. This can be ascribed to the increasing use of these kits at point-of-care settings for the qualitative assessment of drugs and/or their metabolites in human urine for screening, diagnostic purposes, and forensic use.

Browse full report at:

In November 2017, Thermo Fisher Scientific Inc. announced the launch of Thermo Scientific TruNarc handheld narcotics analyzer. This narcotic analyzer can detect Carfentanil, a fentanyl analog, which is 10,000 times more powerful than morphine.

Siemens AG, Merck KGaA, Drägerwerk AG & Co. KGaA, bioMérieux S.A., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories Inc., Abbott Laboratories, Quest Diagnostics Inc., Danaher Corporation, Bioventix Plc, Express Diagnostics Int’l Inc., Psychemedics Corporation, and Lipomed AG are other key players present in the European DOA testing market.

Source: P&S Intelligence

Charger d'autres articles liés
Charger d'autres écrits par healthcarenewswire
Charger d'autres écrits dans Healthcare

Laisser un commentaire

Consulter aussi

Mass Spectrometry Market Trends, Share, Growth and Future Scope

The demand for mass spectrometry is growing rapidly in life science and clinical sector. S…